TP53 and cancer: Altogether, as depicted in Figure 7, these lines of evidence indicate that the Gb3‐cSrc interaction may very well play a key role in regulating the expression of p53‐R273H mutant protein, which could account for cancer resistance to various chemotherapeutic drugs.